BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 34602362)

  • 1. Risk factors and survival outcomes for upstaging after inguinal lymph node dissection for cN1 penile squamous cell carcinoma.
    Chakiryan NH; Dahmen A; Bandini M; Pederzoli F; Marandino L; Albersen M; Roussel E; Zhu Y; Ye DW; Ornellas AA; Catanzaro M; Hakenberg OW; Heidenreich A; Haidl F; Watkin N; Ager M; Briganti A; Salvioni R; Montorsi F; Necchi A; Spiess PE
    Urol Oncol; 2021 Dec; 39(12):838.e7-838.e13. PubMed ID: 34602362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Penile Squamous Cell Carcinoma Patients Undergoing Inguinal Lymph Node Dissection.
    Azizi M; Peyton CC; Boulware DC; Chipollini J; Juwono T; Pow-Sang JM; Spiess PE
    Eur Urol Focus; 2019 Nov; 5(6):1085-1090. PubMed ID: 29937330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of Recurrence following Inguinal Lymph Node Dissection for Penile Cancer: Optimizing Surveillance Strategies.
    Chakiryan NH; Dahmen A; Bandini M; Pederzoli F; Marandino L; Albersen M; Roussel E; Zhu Y; Ye DW; Ornellas AA; Catanzaro M; Hakenberg OW; Heidenreich A; Haidl F; Watkin N; Ager M; Chahoud J; Briganti A; Salvioni R; Montorsi F; Necchi A; Spiess PE
    J Urol; 2021 Oct; 206(4):960-969. PubMed ID: 34032492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of inguinal lymph node dissection in men with urethral squamous cell carcinoma.
    Werntz RP; Riedinger CB; Fantus RJ; Smith ZL; Packiam VT; Adamsky MA; Smith N; Steinberg GD
    Urol Oncol; 2018 Dec; 36(12):526.e1-526.e6. PubMed ID: 30446445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bilateral inguinal lymph-node dissection vs. unilateral inguinal lymph-node dissection and dynamic sentinel node biopsy in clinical N1 squamous cell carcinoma of the penis.
    Nazzani S; Catanzaro M; Biasoni D; Maccauro M; Stagni S; Torelli T; Macchi A; Bernasconi V; Taverna A; Sessa D; Lorenzoni A; Piva L; Lanocita R; Cascella T; Cattaneo L; Montanari E; Salvioni R; Nicolai N
    Urol Oncol; 2023 Apr; 41(4):210.e1-210.e8. PubMed ID: 36868883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term followup of penile carcinoma with high risk for lymph node invasion treated with inguinal lymphadenectomy.
    Marconnet L; Rigaud J; Bouchot O
    J Urol; 2010 Jun; 183(6):2227-32. PubMed ID: 20399455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Penile carcinoma (pT1 G2): surveillance or inguinal lymph node dissection?
    Naumann CM; Filippow N; Seif C; van der Horst C; Roelver L; Braun PM; Juenemann KP; Portillo FJ
    Onkologie; 2005 Mar; 28(3):135-8. PubMed ID: 15772463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risks and Benefits of Adjuvant Radiotherapy After Inguinal Lymphadenectomy in Node-positive Penile Cancer: A Systematic Review by the European Association of Urology Penile Cancer Guidelines Panel.
    Robinson R; Marconi L; MacPepple E; Hakenberg OW; Watkin N; Yuan Y; Lam T; MacLennan S; Adewuyi TE; Coscione A; Minhas SS; Compérat EM; Necchi A
    Eur Urol; 2018 Jul; 74(1):76-83. PubMed ID: 29703686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of the lymph nodes in penile cancer.
    Heyns CF; Fleshner N; Sangar V; Schlenker B; Yuvaraja TB; van Poppel H
    Urology; 2010 Aug; 76(2 Suppl 1):S43-57. PubMed ID: 20691885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymph node metastasis in intermediate-risk penile squamous cell cancer: a two-centre experience.
    Hughes BE; Leijte JA; Kroon BK; Shabbir MA; Swallow TW; Heenan SD; Corbishley CM; van Boven HH; Perry MJ; Watkin NA; Horenblas S
    Eur Urol; 2010 Apr; 57(4):688-92. PubMed ID: 19647926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in Survival Associated with Performance of Lymph Node Dissection in Patients with Invasive Penile Cancer: Results from the National Cancer Database.
    Correa AF; Handorf E; Joshi SS; Geynisman DM; Kutikov A; Chen DY; Uzzo RG; Viterbo R; Greenberg RE; Smaldone MC
    J Urol; 2018 May; 199(5):1238-1244. PubMed ID: 29248557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant docetaxel, cisplatin and ifosfamide (ITP) combination chemotherapy for treating penile squamous cell carcinoma patients with terminal lymph node metastasis.
    Xu J; Li G; Zhu SM; Cai QL; Wang Z; Yang X; Zhang HT; Niu YJ
    BMC Cancer; 2019 Jun; 19(1):625. PubMed ID: 31238987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of Nodal Upstaging in Clinical Node Negative Patients With Penile Carcinoma: A National Cancer Database Analysis.
    Winters BR; Mossanen M; Holt SK; Lin DW; Wright JL
    Urology; 2016 Oct; 96():29-34. PubMed ID: 27450944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usage and survival implications of surgical staging of inguinal lymph nodes in intermediate- to high-risk, clinical localized penile cancer: A propensity-score matched analysis.
    Woldu SL; Ci B; Hutchinson RC; Krabbe LM; Singla N; Passoni NM; Clinton TN; Raj GV; Miller DS; Sagalowsky AI; Lotan Y; Xie Y; Margulis V; Bagrodia A
    Urol Oncol; 2018 Apr; 36(4):159.e7-159.e17. PubMed ID: 29288008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying an optimal lymph node yield for penile squamous cell carcinoma: prognostic impact of surgical dissection.
    Chipollini J; Azizi M; Lo Vullo S; Mariani L; Zhu Y; Ye DW; Ornellas AA; Watkin N; Ager M; Hakenberg O; Heidenreich A; Raggi D; Catanzaro M; Ornellas P; Salvioni R; Cheriyan SK; Necchi A; Spiess PE
    BJU Int; 2020 Jan; 125(1):82-88. PubMed ID: 31356716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of dynamic sentinel lymph node biopsy in patients with squamous cell carcinoma of the penis and palpable inguinal nodes.
    Heyns CF; Theron PD
    BJU Int; 2008 Aug; 102(3):305-9. PubMed ID: 18410439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-port robotic inguinal lymph node dissection: A safe and feasible option for penile cancer.
    Patel AS; Isharwal S
    Surg Oncol; 2021 Sep; 38():101633. PubMed ID: 34332496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimising the selection of candidates for neoadjuvant chemotherapy amongst patients with node-positive penile squamous cell carcinoma.
    Bandini M; Albersen M; Chipollini J; Pederzoli F; Zhu Y; Ye DW; Ornellas AA; Watkin N; Ager M; Hakenberg OW; Heidenreich A; Raggi D; Catanzaro M; Haidl F; Mazzone E; Marandino L; Briganti A; Montorsi F; Azizi M; Spiess PE; Necchi A
    BJU Int; 2020 Jun; 125(6):867-875. PubMed ID: 32175663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymph node yield as a predictor of overall survival following inguinal lymphadenectomy for penile cancer.
    Soodana-Prakash N; Koru-Sengul T; Miao F; Lopategui DM; Savio LF; Moore KJ; Johnson TA; Alameddine M; Barboza MP; Parekh DJ; Punnen S; Gonzalgo ML; Ritch CR
    Urol Oncol; 2018 Oct; 36(10):471.e19-471.e27. PubMed ID: 30143385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is there a benefit to adjuvant radiation in stage III penile cancer after lymph node dissection? Findings from the National Cancer Database.
    Winters BR; Kearns JT; Holt SK; Mossanen M; Lin DW; Wright JL
    Urol Oncol; 2018 Mar; 36(3):92.e11-92.e16. PubMed ID: 29174944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.